(Q33349410)

English

Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

chemoradiotherapy

0 references

pancreatic cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Wing-Kai Chan

4

0 references

author name string

Chung-Pin Li

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Yee Chao

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kwan-Hwa Chi

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ho-Chung Teng

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Rheun-Chuan Lee

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Full-Young Chang

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Shou-Dong Lee

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sang-Hue Yen

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

57

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

98-104

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900435-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900435-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900435-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900435-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900435-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900435-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic index

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900435-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900435-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of weekly gemcitabine as a radiation sensitizer for unresectable pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900435-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine following radiotherapy with concurrent 5-fluorouracil for nonmetastatic adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900435-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation therapy combined with Adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900435-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900435-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900435-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900435-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(03)00435-8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33349410&oldid=1970926850"